AG
AVEO

Aperio Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Aperio Group’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,067
Closed -$12K – 1928
2014
Q3 		$12K Sell
1,067
-292
-21% -$3.71K ﹤0.01% 1741
2014
Q2 		$25K Sell
1,359
-4,105
-75% -$53.4K ﹤0.01% 1725
2014
Q1 		$82K Buy
+5,464
New +$98.1K ﹤0.01% 1986
2013
Q4 		– Sell
-1,083
Closed -$21.7K – 1829
2013
Q3 		$22K Buy
+1,083
New +$24.8K ﹤0.01% 1795

Other funds holding AVEO

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DVC
Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GX
Greylock XI Cambridge, Massachusetts $7.71M AUM 28.23% 1-Year Est. Return

Aperio Group's AVEO Position: Q4 2014 in Review

Aperio Group sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2014, closing a stake of 1,067 shares — an estimated $12K sold.

Aperio Group first reported a position in AVEO in Q3 2013 and held it in 4 quarters. The position peaked at $82K in Q1 2014. 51 funds tracked by Wall St. Rank hold AVEO as of Q4 2014.

  • Aperio Group reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Aperio Group sold 1,067 AVEO Pharmaceuticals, Inc. shares in Q4 2014, an estimated $12K.
  • Aperio Group first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2013 and held it in 4 quarters.
  • Aperio Group's AVEO Pharmaceuticals, Inc. position peaked at $82K in Q1 2014.
  • 51 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2014.

Based on Aperio Group's 13F filing for Q4 2014, filed 30 Jan 2015.